Comparative analysis identifies key differences in medical AI and data governance in the EU and Japan, suggesting policy harmonization implications.
This study conducts a comparative analysis of regulatory frameworks for medical AI and data governance in the EU and Japan, highlighting their differing approaches and implications for international policy development. By examining these frameworks, the study identifies critical factors for effective governance and offers recommendations for international policy harmonization.
No takes yet. Share an insight, caveat, or question.
Takanori Fujita (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: